Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
11 pending office actions • 5 art units • 8 examiners • 0 of 11 (0%) have an AI response strategy ready • 7 patents granted in the last 365 days
Curium US LLC currently has 10 pending office actions within the Biotechnology & Pharmaceuticals technology area. These 10 actions are being handled by 7 distinct examiners, which indicates a moderate concentration of matters among the assigned personnel. The portfolio is also distributed across 4 distinct art units, suggesting that the company's Biotechnology & Pharmaceuticals applications are evaluated by several specialized technical groups within the patent office.
The busiest examiner for the portfolio is Donohue, Sean R, who is responsible for 3 of the pending office actions. Since Donohue, Sean R manages 3 out of the 10 total actions, this examiner's specific feedback and requirements will be a significant factor in the company's current prosecution efforts. The 4 distinct art units involved mean that the 10 pending office actions are subject to the specific guidelines of four different examination groups, requiring a tailored approach for each case.
Practitioners managing these 10 pending office actions must prioritize the relationship with Donohue, Sean R, given their oversight of 3 cases. The presence of 7 distinct examiners and 4 distinct art units for 10 actions shows that the portfolio is distributed across multiple procedural silos. This distribution requires a strategy that addresses the specific technical nuances of each Biotechnology & Pharmaceuticals art unit while managing the influence of the busiest examiner on the overall portfolio.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 4 (36%) |
| Double-patenting + other | 4 (36%) |
| Multi-statute (no §101) | 3 (27%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| DONOHUE, SEAN R | 3 | 41.4% | +21.0% |
| WESTERBERG, NISSA M | 2 | 23.4% | +37.1% |
| SAMALA, JAGADISHWAR RAO | 1 | 68.0% | +55.6% |
| RUFO, LOUIS J | 1 | 54.4% | +22.9% |
| CRAIG, KAILA ANGELIQUE | 1 | 33.8% | +25.2% |
| VU, JAKE MINH | 1 | 41.1% | +27.2% |
| LEWOCZKO, EVAN MICHAEL | 1 | — | — |
| SMYTH, ANDREW P | 1 | 71.7% | +14.5% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 5 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 19573690 | PURIFICATION PROCESS FOR THE PREPARATION OF NON-CARRIER ADDED COPPER-64 | SAMALA, JAGADISHWAR RAO | — |
| 19419876 | METHODS AND COMPOSITIONS FOR ELECTRODEPOSITION | RUFO, LOUIS J | — |
| 18745888 | COPPER-64 COMPOSITIONS AND PURIFICATION PROCESSES FOR THE PREPARATION OF NOVEL COPPER-64 COMPOSITIONS | WESTERBERG, NISSA M | — |
| 18681264 | RADIOPHARMACEUTICAL COMPOSITIONS FOR LOW TOXICITY ACTINIUM IN TARGETED RADIONUCLIDE THERAPY | VU, JAKE MINH | — |
| 18354581 | RADIOPHARMACEUTICAL COMPOSITIONS OF COPPER FOR TARGETED MOLECULAR IMAGING | WESTERBERG, NISSA M | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 19573690 | PURIFICATION PROCESS FOR THE PREPARATION OF NON-CARRIER ADDED COPPER-64 | SAMALA, JAGADISHWAR RAO | — |
| 19419876 | METHODS AND COMPOSITIONS FOR ELECTRODEPOSITION | RUFO, LOUIS J | — |
| 19209267 | [177LU] LUTETIUM-PSMA I&T COMPOSITION AND DOSIMETRY, KIT, METHOD OF MAKING, AND METHOD OF USING THEREOF | DONOHUE, SEAN R | — |
| 19208200 | [177LU] LUTETIUM-PSMA I&T COMPOSITION AND DOSIMETRY, KIT, METHOD OF MAKING, AND METHOD OF USING THEREOF | DONOHUE, SEAN R | — |
| 18798723 | METHOD OF DETECTING PROSTATE CANCER IN A HUMAN SUBJECT USING A Cu 64 PSMA I&T INJECTION | CRAIG, KAILA ANGELIQUE | — |
| 18756231 | RADIOLABELING AND FORMULATION FOR SCALE UP OF 64Cu-DOTATATE | DONOHUE, SEAN R | — |
| 18745888 | COPPER-64 COMPOSITIONS AND PURIFICATION PROCESSES FOR THE PREPARATION OF NOVEL COPPER-64 COMPOSITIONS | WESTERBERG, NISSA M | — |
| 18681264 | RADIOPHARMACEUTICAL COMPOSITIONS FOR LOW TOXICITY ACTINIUM IN TARGETED RADIONUCLIDE THERAPY | VU, JAKE MINH | — |
| Art Unit | Apps |
|---|---|
| 1618 | 6 |
| 1795 | 1 |
| 4100 | 1 |
| 1612 | 1 |
| 2878 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19573690 | PURIFICATION PROCESS FOR THE PREPARATION OF NON-CARRIER ADDED COPPER-64 | SAMALA, JAGADISHWAR RAO | 1618 | §102§103Other | Final Rejection | — | Pending | Mar 20, 2026 |
| 19419876 | METHODS AND COMPOSITIONS FOR ELECTRODEPOSITION | RUFO, LOUIS J | 1795 | §102§103 | Final Rejection | — | Pending | Dec 15, 2025 |
| 19209267 | [177LU] LUTETIUM-PSMA I&T COMPOSITION AND DOSIMETRY, KIT, METHOD OF MAKING, AND METHOD OF USING THEREOF | DONOHUE, SEAN R | 1618 | §103 | Non-Final OA | — | Pending | May 15, 2025 |
| 19208200 | [177LU] LUTETIUM-PSMA I&T COMPOSITION AND DOSIMETRY, KIT, METHOD OF MAKING, AND METHOD OF USING THEREOF | DONOHUE, SEAN R | 1618 | §103 | Non-Final OA | — | Pending | May 14, 2025 |
| 18798723 | METHOD OF DETECTING PROSTATE CANCER IN A HUMAN SUBJECT USING A Cu 64 PSMA I&T INJECTION | CRAIG, KAILA ANGELIQUE | 1618 | §103 | Final Rejection | — | Pending | Aug 08, 2024 |
| 18756231 | RADIOLABELING AND FORMULATION FOR SCALE UP OF 64Cu-DOTATATE | DONOHUE, SEAN R | — | §102§103§112DP | Non-Final OA | — | Pending | Jun 27, 2024 |
| 18745888 | COPPER-64 COMPOSITIONS AND PURIFICATION PROCESSES FOR THE PREPARATION OF NOVEL COPPER-64 COMPOSITIONS | WESTERBERG, NISSA M | 4100 | §103§112DP | Non-Final OA | — | Pending | Jun 17, 2024 |
| 18681264 | RADIOPHARMACEUTICAL COMPOSITIONS FOR LOW TOXICITY ACTINIUM IN TARGETED RADIONUCLIDE THERAPY | VU, JAKE MINH | 1618 | §102§103§112Other | Non-Final OA | — | Pending | Feb 05, 2024 |
| 18228510 | [177LU] LUTETIUM-PSMA I&T COMPOSITION, KIT, METHOD OF MAKING, AND METHOD OF USING THEREOF | LEWOCZKO, EVAN MICHAEL | 1612 | §103§112DP | Final Rejection | — | Pending | Jul 31, 2023 |
| 18354581 | RADIOPHARMACEUTICAL COMPOSITIONS OF COPPER FOR TARGETED MOLECULAR IMAGING | WESTERBERG, NISSA M | 1618 | §103§112DP | Non-Final OA | — | Pending | Jul 18, 2023 |
| 18043250 | CONTAINER CLOSURE INCLUDING VORTEX-GENERATING FEATURE | SMYTH, ANDREW P | 2878 | §103 | Non-Final OA | — | Pending | Feb 27, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial